Market Tracker

02/23 11:17am ET

Intercept Pharmaceuticals Inc (NASDAQ:ICPT)

112.57
BATS BZX Real-Time Price
As of 11:16am ET
 -10.22 / -8.32%
Today’s Change
96.63
Today|||52-Week Range
177.93
+3.61%
Year-to-Date
Intercept (ICPT) Reports a Wider Q4 Loss
9:59am / Zacks.com - Paid Partner Content
Investors Are Betting Big Against Intercept Pharmaceuticals. Are They Wrong?
Feb 17 / MotleyFool.com - Paid Partner Content
Drug Stocks Q4 Earnings Slated for Feb 23: BMRN, ICPT & More
Feb 22 / Zacks.com - Paid Partner Content
Why Intercept Pharmaceuticals' Latest News Caused the Stock to Jump
Feb 11 / MotleyFool.com - Paid Partner Content
Intercept (ICPT) to Post Q4 Earnings: What's in the Cards?
Feb 21 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close122.79
Today’s open122.01
Day’s range112.00 - 122.01
Volume28,328
Average volume (3 months)506,465
Market cap$3.0B
Dividend yield--
Data as of 11:16am ET, 02/23/2017

Growth & Valuation

Earnings growth (last year)+29.86%
Earnings growth (this year)-63.41%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)+59.74%
P/E ratioNM
Price/Sales1,272.01
Price/Book4.97

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Brands Hold...+0.02+0.04%
GWPHGW Pharmaceuticals P...-1.24-0.99%
CBPOChina Biologic Produ...+1.85+1.73%
GLPGGalapagos NV-0.04-0.06%
Data as of 11:16am ET, 02/23/2017

Financials

Last reporting dateFebruary 23, 2017
EPS forecast (this quarter)-$3.72
Annual revenue (last year)$2.8M
Annual profit (last year)-$226.4M
Net profit margin-8,139.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Mark E. Pruzanski
Chief Financial Officer
Sandip Kapadia
Corporate headquarters
New York, New York

Forecasts